AbbVie’s $10.9B Apogee deal strengthens immunology beyond Humira, adds Zumilokibart optionality, and may be undervalued. See ...

AbbVie gains attention as healthcare rotation highlights Skyrizi, Rinvoq, immunology growth, and portfolio strength beyond ...

OpenAI announced a new feature that it says will provide additional protection from prompt injection attacks, where malicious chatbot instructions are hidden in web pages and other content sources.

AbbVie bolsters its already solid immunology platform. Immunology is AbbVie's primary core competency. While the ...

While these patent cliffs are still some ways away, considering the time it takes to develop brand-new therapies, now is as good a time as any for AbbVie to start figuring out how it will overcome ...

Lockdown Mode is an optional, advanced security setting that restricts the tools and features that OpenAI products can use to connect to the web and external services. Simply put, Lockdown Mode ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Neo-B12 Injection contains the active ingredient hydroxocobalamin. Neo ...

Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Wegovy is available as an injection and an oral tablet. Wegovy injection is approved by the FDA for weight management, cardiovascular risk reduction, and liver disease. The tablet is approved for ...

Glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists help manage blood sugar in type 2 diabetes. They may also support ...